Singapore markets closed
Straits Times Index
3,092.11 -6.14 (-0.20%) S&P 500
4,513.04 -53.96 (-1.18%) Dow
34,022.04 -461.68 (-1.34%) Nasdaq
15,254.05 -283.64 (-1.83%) BTC-USD
56,855.02 -137.55 (-0.24%) CMC Crypto 200
1,448.10 -20.98 (-1.43%)
Cassava Sciences, Inc. (SAVA)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
Pre-market:
| Previous close | 53.49 |
| Open | 53.65 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1000 |
| Day's range | 48.07 - 53.72 |
| 52-week range | 6.70 - 146.16 |
| Volume | |
| Avg. volume | 6,946,826 |
| Market cap | 1.952B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.56 |
| Earnings date | 10 Nov 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 13 Dec 2012 |
| 1y target est | 159.25 |
- Zacks
Is the Options Market Predicting a Spike in Cassava Sciences (SAVA) Stock?
Investors need to pay close attention to Cassava Sciences (SAVA) stock based on the movements in the options market lately.
- Zacks
Biogen's (BIIB) Aducanumab Gets CHMP's Negative Trend Vote
Biogen's (BIIB) regulatory application seeking approval for its Alzheimer's drug, Aduhelm, in Europe hits setback as it receives negative trend vote from the CHMP.
- Zacks
Cassava (SAVA) Down on Report of SEC Investigation Into AD Program
Cassava (SAVA) tanks on reports of an investigation by the SEC related to data reports on its AD candidate.
© 2021 Yahoo. All rights reserved.
